Stronger 6-12h Distribution
Late-stage distribution is stronger from 6-12h.
Peptide addition broadens late-stage distribution in 5% VC serum.
NOVA
More efficient delivery, more visible efficacy, and greater safety confidence
5%
VC level
Late-stage distribution is stronger from 6-12h.
Claim stays within the 5% VC formula context.
VC also serves as a positive control.
NOVA
Human skin penetration study results
Results generated from human skin studies, with data captured using Raman spectroscopy-based research instruments.
Peptide broadens late-stage VC distribution.

Study snapshots and supporting takeaways

Efficacy
In vitro efficacy covers anti-wrinkle, anti-glycation, antioxidant, and repair directions.

Safety
Patch test: all 30 subjects stayed at grade 0.
From partner companies

N1 Care
Brightening Serum

N1 Care
Radiance Face Cream

N1 Care
Scalp Nourishing Serum
NOVA